Your browser doesn't support javascript.
loading
FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer.
Nadal, Cristina; Maurel, Joan; Gallego, Rosa; Castells, Antoni; Longarón, Raquel; Marmol, Maribel; Sanz, Sergi; Molina, Rafael; Martin-Richard, Marta; Gascón, Pere.
Affiliation
  • Nadal C; Medical Oncology, Institut Malalties Hemato-Oncologiques, Gastroenterology Department, Hospital Clinic Barcelona, Institut d'Investigacions Bimédiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
Clin Cancer Res ; 11(13): 4770-4, 2005 Jul 01.
Article in En | MEDLINE | ID: mdl-16000573
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Fas Receptor / Tumor Necrosis Factors Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2005 Document type: Article Affiliation country:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Fas Receptor / Tumor Necrosis Factors Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2005 Document type: Article Affiliation country: